Retinopathy in Relation to Albuminuria and Blood Pressure in IDDM

  • Nish Chaturvedi
  • John H. Fuller

Abstract

The microvascular complications of diabetes, retinopathy and nephropathy, are often considered as a single entity, with the implicit assumption of a close correlation between these complications, both in tenns of occurrence, and in terms of putative risk factors 1–3. It is certainly true that patients with one complication will generally demonstrate signs of the other, and that glycaemic control and duration of diabetes are clear risk factors for each of these complications 4–10. But in contrast, current evidence indicates that while the majority of patients with IDDM will develop retinopathy (estimates vary from 70% to 100%) [11–13], only about a third of patients will develop detectable nephropathy [2,14], even when glycaemic control is poor, and the duration of diabetes is long [2,15].

Keywords

Diabetic Retinopathy Glycaemic Control Albumin Excretion Rate IDDM Patient Poor Glycaemic Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Root HF, Pote WH, Frehner H. Triopathy of diabetes: a sequence of neuropathy, retinopathy and nephropathy. Arch Intern Med 1954; 94:931–941.CrossRefGoogle Scholar
  2. 2.
    Chavers BM, Mauer SM, Ramsay RC, Steffes MW. Relationship between retinal and glomerular lesions in IDDM patients. Diabetes 1994; 43: 441–446.PubMedCrossRefGoogle Scholar
  3. 3.
    Johansen J, Sjolie AK, Elbol P, Eshoj O. The relation between retinopathy and albumin excretion rate in insulin-dependent diabetes mellitus. From the Funen County Epidemiology of Type 1 Diabetes Complications Survey. Acta Ophthalmol Copenh 1994; 72:347–351.PubMedCrossRefGoogle Scholar
  4. 4.
    Watts GF, Harris R, Shaw KM. The determinants of early nephropathy in insulin- dependent diabetes mellitus: a prospective study based on the urinary excretion of albumin. Quarterly J Med 1991; 79: 365–378.Google Scholar
  5. 5.
    Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycaemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994; 154:2169–2178.PubMedCrossRefGoogle Scholar
  6. 6.
    Teuscher A, Scnhell H, Wilson PW. Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care 1988; 11:246–251.PubMedCrossRefGoogle Scholar
  7. 7.
    Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986; 35:1332–1339.PubMedCrossRefGoogle Scholar
  8. 8.
    Nieken NV. Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol Copenh 1984; 62:256–265.Google Scholar
  9. 9.
    Chase HP, Garg SK, Jackson WE. Blood pressure and retinopathy in type 1 diabetes. Ophthalmology 1990,97: 155–159. P8’4PubMedGoogle Scholar
  10. 10.
    Coonrod BA, Ellis D, Becker DJ, et al. Predictors of microalbuminuria in individuals with IDDM P ittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 1993; 16:1376–1383.PubMedCrossRefGoogle Scholar
  11. 11.
    Danielsen R, Jonasson F, Helgason T. Prevalence of retinopathy and proteinuria in type 1 diabetics in Iceland. Acta Med Scand 1982; 212:277–280.PubMedCrossRefGoogle Scholar
  12. 12.
    Dwyer MS, Melton LJ, Ballard DJ, Palumbo PJ, Trautmann JC, Chu CP. Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. Diabetes Care 1985; 8: 316–322.PubMedCrossRefGoogle Scholar
  13. 13.
    Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520–526.PubMedCrossRefGoogle Scholar
  14. 14.
    Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiologic study. Diabetologia 1983; 25: 496–501.PubMedCrossRefGoogle Scholar
  15. 15.
    Stephenson JM, Fuller JH, Viberti GC, Sjolie AK, Navalesi R, EURODIAB IDDM Complications Study Group. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia 1995; 38: 599–603.PubMedCrossRefGoogle Scholar
  16. 16.
    Parving HH, Smidt UM, Frisberg B, Bonnevie-Nielsen V, Andersen AR. A prospective study of glomerular filtration rate and arterial blood pressure in insulin- dependent diabetes with diabetic nephropathy. Diabetologia 1981; 20: 457–461.PubMedCrossRefGoogle Scholar
  17. 17.
    Mogensen CE, Christensen CK Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.PubMedCrossRefGoogle Scholar
  18. 18.
    Krolewski AS, Canessa M, Warram JH. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140–145.PubMedCrossRefGoogle Scholar
  19. 19.
    Mogensen CE, Østerby R, Hansen KW, Damsgaard EM. Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care 1992; 15: 1181–1204.CrossRefGoogle Scholar
  20. 20.
    West KM, Erdreich LJ, Stober A. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 1980; 29: 501–508.PubMedCrossRefGoogle Scholar
  21. 21.
    Janka HU, Warram JH, Rand LI, Krolewski AS. Risk factors for progression of background retinopathy in long-standing IDDM Diabetes 1989; 38: 460–464.CrossRefGoogle Scholar
  22. 22.
    Klein BE, Klein R, Moss SE, Palta M A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol 1995; 113:601–606.PubMedCrossRefGoogle Scholar
  23. 23.
    Norgaard K, Feldt-Rasmussen B, Deckert T. Is hypertension a major risk factor for retinopathy in type 1 diabetes? Diabetic Med 1991; 8: 334–337.PubMedCrossRefGoogle Scholar
  24. 24.
    Krolewski AS, Warram JH, Cupples A, Gorman CK, Szabo AJ, Christlieb AR. Hypertension, orthostatic hypotension and the microvascular complications of diabetes. J Chronic Dis 1985; 38: 319–326.PubMedCrossRefGoogle Scholar
  25. 25.
    Vigstrup J, Mogensen CE. Proliferative diabetic retinopathy: at risk patients identified by early detection of microalbuminuria. Acta Opthalmol 1985; 63: 530–534. P8’4CrossRefGoogle Scholar
  26. 26.
    The EURODIAB IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278–285.CrossRefGoogle Scholar
  27. 27.
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.CrossRefGoogle Scholar
  28. 28.
    Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.PubMedCrossRefGoogle Scholar
  29. 29.
    Sosenko JM, Breslow JL, Miettinen OS, Gabbay KH. Hyperglycaemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. N Engl J Med 1980; 302: 650–654.PubMedCrossRefGoogle Scholar
  30. 30.
    Jensen T, Stender S, Deckert T. Abnormalities in plamsa concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 1988;31:142–145.PubMedCrossRefGoogle Scholar
  31. 31.
    Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J 1989; 298: 487–490.CrossRefGoogle Scholar
  32. 32.
    Stehouwer CD, Stroes ES, Hackeng WH, Mulder PG, Den-Ottolander GJ. von Willebrand factor and development of diabetic nephropathy in IDDM. Diabetes 1991; 40:971–976.PubMedCrossRefGoogle Scholar
  33. 33.
    Stehouwer CD, Fischer HR, van-Kuijk AW, Polak BC, Donker AJ. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 1995; 44: 561–564.PubMedCrossRefGoogle Scholar
  34. 34.
    Winocour PH, Durringon PN, Ishola M, Anderson DC, Cohen H. Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J 1987; 294: 1648–1651.CrossRefGoogle Scholar
  35. 35.
    Tamow L, Cambien F, Rossing P, et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489–393.CrossRefGoogle Scholar
  36. 36.
    Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane BF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118: 129–138.PubMedCrossRefGoogle Scholar
  37. 37.
    Chase HP, Garg SK, Harris S, Hoops S, Jackson WE, Holmes DL. Angiotensin- Converting Enzyme Inhibitor Treatment for Young Normotensive Diabetic Subjects: A Two-Year Trial. Arm Opthalmol 1993; 25:284–289.Google Scholar
  38. 38.
    Larsen M, Hommd E, Parvmg HH, Lund-Andersen H. Protective effect of Captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. Graefes Arch Clin Exp Ophthalmol 1990; 228: 505–509.PubMedCrossRefGoogle Scholar
  39. 39.
    Chaturvedi N, Sjolie A-K, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998; 351:28–31.PubMedCrossRefGoogle Scholar
  40. 40.
    Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M long-term stabalising effect of angiotensm-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensivetype II diabetic patients. Ann Intern Med 1993; 118: 577–581.PubMedCrossRefGoogle Scholar
  41. 41.
    Wagner J, Danser AHJ, Derkx FHM, et al. Demonstration of renin mRNA, angiotensin mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 1996; 80:159–163.PubMedCrossRefGoogle Scholar
  42. 42.
    Danser AHJ, Derkx FHM, Admiraal PJJ, Deinum J, De Jong PTVM, Schalekamp MADH. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 1994; 35:1008–1018.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • Nish Chaturvedi
    • 1
  • John H. Fuller
    • 1
  1. 1.EURODIAB, Department of Epidemiology and Public HealthUniversity CollegeLondonUK

Personalised recommendations